Idiopathic pulmonary fibrosis
Conditions
Interventions
Experimental group:FTP-198
control group:placebo
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 45 years, both male and female, and the BMI (weight (Kg)/height (m) square) is 19 to 24; 2. Qualified in the comprehensive physical examination, with normal blood and urine routine, liver and kidney function tests and electrocardiogram, and negative hepatitis B surface antigen; 3. Voluntarily take the test after understanding the content of the test, and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Those with a history of drug and food allergies, allergic diseases or allergic constitution; 2. Those with a history of chronic or organic diseases or existing heart, liver, kidney and blood system diseases; 3. Participated in other drug trials within 2 months before the trial; 4. Those who have participated in blood donation within 3 months before the test; 5. Those who have used any medicine (including traditional Chinese medicine) within 2 weeks; 6. Those who often use drugs, drink alcohol or smoke; those who have poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| plasma drug concentration; | — |
Secondary
| Measure | Time frame |
|---|---|
| pharmacodynamic parameter; | — |
Countries
China
Contacts
Public ContactLuo Zhu
West China Hospital, Sichuan University
Outcome results
None listed